Efficacy and hypoglycemic risk of sitagliptin in obese/overweight patients with type 2 diabetes compared with GLP-1 receptor agonists-Reference-Cited by-同舟云学术

Efficacy and hypoglycemic risk of sitagliptin in obese/overweight patients with type 2 diabetes compared with GLP-1 receptor agonists

Published:2019-09 Issue:36 Volume:98 Page:e17081
ISSN:0025-7974
Container-title:Medicine
language:en
Short-container-title:

Author:

Dai Danping,Mao Yiyang,Jin Haiying,Zhang Wei

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference24 articles.

1. Effects of a combination of sitagliptin plus metformin vs metformin monotherapy on glycemic control, b-cell function and insulin resistance in type 2 diabetic patients;Derosa;Diabetes Res Clin Pract,2012

2. Risk factors contributing to type 2 diabetes and recent advances in the treatment and prevention;Wu;Int J Med Sci,2014

3. The worldwide epidemiology of type 2 diabetes mellitus—present and future perspectives;Chen;Nat Rev Endocrinol,2011

4. Obesity and Diabetes;Serván;Nutr Hosp,2013

5. Sitagliptin/metformin versus insulin glargine combined with metformin in obese subjects with newly diagnosed type 2 diabetes;Ji;Medicine (Abingdon),2016

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of Liraglutide on Weight Loss and BMI Among Patients Who Are Overweight and Obese with Type 2 Diabetes: A Systematic Review and Meta-analysis;European Medical Journal;2023-12-14

2. Comparative efficacy and safety profile of once-weekly Semaglutide versus once-daily Sitagliptin as an add-on to metformin in patients with type 2 diabetes: a systematic review and meta-analysis;Annals of Medicine;2023-07-27

3. Cost-Effectiveness of Dipeptidylpeptidase-4 Inhibitors Added to Metformin in Patients With Type 2 Diabetes in China;Frontiers in Endocrinology;2021-08-13

4. Pathogenetic Changes in the Expression of Apoptotic Marker Caspase-3 in Patients with Type IІ Diabetes Mellitus and Excess Body Weight and Obesity;Ukraïnsʹkij žurnal medicini, bìologìï ta sportu;2020-11-01

5. Osteoporosis and Hepatic Steatosis: 2 Closely Related Complications in Short‐Bowel Syndrome;Journal of Parenteral and Enteral Nutrition;2020-02-12